Navigation Links
Columbus Cancer Foundation Honors Legendary Explorer
Date:10/9/2009

PHILADELPHIA, Oct. 9 /PRNewswire-USNewswire/ -- The Sbarro Health Research Organization (www.shro.org) at Temple University has launched the Columbus Cancer Foundation (www.columbuscancerfoundation.org), a nonprofit organization that will raise funds for joint American and European educational initiatives, basic and clinical cancer research and international scientific collaboration.

The name was chosen in honor of the courage and conviction with which Christopher Columbus embarked across unknown waters in the search of great discoveries.

"Today, great discoveries occur in laboratories around the world in response to the tragedy of cancer, a condition estimated to affect one out of every four individuals," says Antonio Giordano, M.D., Ph.D., the Founder and President of SHRO. "Fortunately, it is possible to understand, prevent and cure many types of cancer with the assistance of continued research funding which enables the discovery of genetically targeted diagnostic and therapeutic treatments."

"The primary goal of the Columbus Cancer Foundation is to stimulate clinical and laboratory cancer research that will ultimately enable us to develop personalized medicine techniques that will improve the survival and quality of life of cancer patients," explains Cora N. Sternberg, M.D., FACP, the Chairman of the Scientific Advisory Board. "Our mission is to develop, coordinate and conduct programs related to patient care, cutting edge research and education."

"There are many problems which need to be addressed in cancer treatment, including prevention, mechanisms of tumor development, the tumor environment, and mechanisms of response and resistance," says Sternberg. "Patient care will ultimately benefit from our increased understanding of the biology of cancer and possible therapeutic targets, their mechanisms of survival and overcoming resistance to therapy."

Donations to the new foundation can be made online at http://columbuscancerfoundation.org/.

An eminent American and Italian Medical Oncologist, Dr. Sternberg is currently the Chairman of the Department of Medical Oncology at San Camillo and Forlanini Hospitals in Rome, Italy, and a Professor at La Sapienza University in the Medical Oncology School of Specialization.

The Sbarro Health Research Organization is a nonprofit research center located at Temple University that conducts genetic and molecular research in cancer, diabetes, and cardiovascular disease. Based in Philadelphia, Pennsylvania, on the campus of Temple University, our programs train young scientists from around the globe.

This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com.

SOURCE Sbarro Health Research Organization


'/>"/>
SOURCE Sbarro Health Research Organization
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Long Term Care Seminars in Dayton, Cleveland, Cincinnati, and Columbus -- Free to Public
2. Kenneth G. Langone, Home Depot Co-Founder, Chairman of the NYU Langone Medical Center, to Lead 65th Annual Columbus Day Parade as Grand Marshal
3. Knights of Columbus Gather in Phoenix for 127th International Convention
4. Aflac Outdoor Games Return to Columbus for a Second Year
5. Ohio Health Care Association/Ohio Centers for Assisted Living Host Midwests Largest Long-Term Care Convention in Columbus
6. Knights of Columbus Ultrasound Program Assists Pregnant Women
7. Irishman with Peripheral Arterial Disease (P.A.D.) Finds Leg-, Life-Saving Treatment In Columbus, Ohio
8. Columbus Medicare Diabetes Screening Project Cited as Model for State by Lt. Governor Casey Cagle
9. Streamline Health(R) Expands into Public Sector with New Customer, Columbus Public Health Vital Statistics Office
10. Kimberly-Clark Professional Donates Supplies to Assist Columbus, Ind., in Flood Cleanup Efforts
11. Ohio Health Care Association Hosts Midwests Largest Long-Term Care Convention in Columbus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association ... Featuring a collection of specialty vendors and unique items from across the nation, this ... health and wellness services offered by the VNA. The boutique will be open ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: